Jaa Roberson

Ufficiale delle Risorse Umane presso DAY ONE BIOPHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profilo

Jaa Roberson is currently the Chief People Officer at Day One Biopharmaceuticals, Inc. Prior to this, she worked as the Head of Human Resources at Achaogen, Inc. and as the Vice President of Human Resources at Bellicum Pharmaceuticals, Inc. from 2018 to 2020.
Ms. Roberson has an undergraduate degree from Rice University and a graduate degree from the San Francisco Conservatory of Music.

Posizioni attive di Jaa Roberson

Società	Posizione	Inizio
DAY ONE BIOPHARMACEUTICALS, INC.	Ufficiale delle Risorse Umane	13/09/2021

Tutte le posizioni attive di Jaa Roberson

Precedenti posizioni note di Jaa Roberson

Società	Posizione	Fine
BELLICUM PHARMACEUTICALS, INC.	Ufficiale delle Risorse Umane	01/11/2020
ACHAOGEN	Ufficiale delle Risorse Umane	-

Vedi nel dettaglio l'esperienza di Jaa Roberson

Formazione di Jaa Roberson

Rice University	Undergraduate Degree
San Francisco Conservatory of Music	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jaa Roberson

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
DAY ONE BIOPHARMACEUTICALS, INC.	Health Technology

Aziende private	2
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.	Health Technology
Achaogen, Inc. Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA.	Health Technology

Aziende private